Strategic Commissioning Could Transform NHS Medicines Decisions
UKPulse Health Desk
Strategic commissioning may transform how decisions are made regarding medicines within the NHS, moving from a focus on costs to creating value.
- Strategic commissioning could transform medicines decision-making in the NHS.
- The approach aims to shift focus from counting costs to creating value.
A new approach to medicines decision-making in the NHS, termed strategic commissioning, is being explored. This method aims to transform current practices by moving beyond simply counting costs to instead focus on creating value within the health service.
The shift in strategy could impact how medicines are evaluated and implemented across the NHS.